- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00290368
Repeat Nasal Allergen Challenge
September 13, 2023 updated by: Imperial College London
Assessment of Inflammatory Mediator and Cellular Changes Following Repeated Nasal Allergen Challenge in Subjects With Allergic Rhinitis Sensitive to Timothy Grass Pollen - a Validation Study
This is a non-drug, biomarker study to assess the utility of the model of repeated nasal allergen challenges in subjects with atopic rhinitis as a method of inducing an increased response to inhaled allergen, which will more closely resemble the responses seen during the hayfever season.
Study Overview
Status
Completed
Conditions
Detailed Description
This is a non-drug, biomarker study to assess the utility of the model of repeated nasal allergen challenges in subjects with atopic rhinitis as a method of inducing an increased response to inhaled allergen, which will more closely resemble the responses seen during the hayfever season.
Study Type
Interventional
Enrollment
22
Phase
- Phase 2
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
London, United Kingdom, SW3 6HP
- National Heart & Lung Institute Clinical Studies Unit
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 40 years (Adult)
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- Male and female subjects with a history of seasonal (intermittent) atopic rhinitis, aged 18-40 years.
- Otherwise healthy with no health problems that may jeopardize the subjects participating in the study, absence of history of other significant allergies.
Exclusion Criteria:
- Smokers (use of tobacco products in the previous 3 months).
- Presence of any respiratory disease other than a history of mild stable asthma not requiring treatment and associated with normal lung function (FEV1 > 80% predicted at screening).
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Trevor T Hansel, FRCPath, Imperial College London
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
February 1, 2006
Study Completion
May 1, 2006
Study Registration Dates
First Submitted
February 10, 2006
First Submitted That Met QC Criteria
February 10, 2006
First Posted (Estimated)
February 13, 2006
Study Record Updates
Last Update Posted (Actual)
September 14, 2023
Last Update Submitted That Met QC Criteria
September 13, 2023
Last Verified
September 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- CPJMR0052104
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hayfever
-
University of California, DavisWithdrawn
-
Radboud University Medical CenterCompleted
-
GlaxoSmithKlineCompletedRhinitis, Allergic, Seasonal | Seasonal Allergic Rhinitis | HayfeverUnited States
-
Teva Branded Pharmaceutical Products R&D, Inc.CompletedSeasonal Allergic Rhinitis | HayfeverUnited States
-
Marinomed Biotech AGCompletedAllergic Rhinitis | Allergic Conjunctivitis | HayfeverAustria
-
University of NottinghamCompletedAllergy | Rhinitis, Allergic, Perennial | HayfeverUnited Kingdom
Clinical Trials on Skin Prick Test
-
HippocreatesCompletedAllergy Pollen | Allergy to House DustBelgium
-
University of ZurichRecruitingHypersensitivity, FoodSwitzerland
-
Prof. Dr. Claus Bachert BVBAUnknownAllergic Rhinitis | Allergic Conjunctivitis | Food Allergy | Allergic Asthma
-
Children's Hospital SrebrnjakIN2 Ltd.RecruitingAllergic Reaction | Child AllergyCroatia
-
Roxall Medicina España S.ACompletedSensitization to AllergensSpain
-
HippocreatesRecruiting
-
Queen Astrid Military HospitalRecruitingAdult Military PersonnelBelgium
-
Mahidol UniversityCompletedAllergic Rhinitis (Disorder)Thailand
-
Roxall Medicina España S.ACompleted
-
University Hospital Plymouth NHS TrustUniversity of PlymouthNot yet recruitingBee Sting